Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Mallinckrodt
Dow
Medtronic
Colorcon

Last Updated: June 28, 2022

Triamcinolone acetonide - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

What are the generic drug sources for triamcinolone acetonide and what is the scope of freedom to operate?

Triamcinolone acetonide is the generic ingredient in twenty-seven branded drugs marketed by Abbvie, Chattem Sanofi, Astellas, Ivax Pharms, Delcor Asset Corp, Teva, Solvay, Actavis Mid Atlantic, Alkem Labs Ltd, Alpharma Us Pharms, Ambix, Cosette, Fougera Pharms, Glenmark Pharms Ltd, Lupin, Macleods Pharms Ltd, Micro Labs, Morton Grove, Mylan, Padagis Us, Pai Holdings Pharm, Pharmaderm, Pharmafair, Strides Pharma, Taro, Taro Pharm Inds Ltd, Topiderm, Crown Labs, Savage Labs, Pacira Pharms Inc, Apothecon, Amneal, Long Grove Pharms, Parnell, Sandoz Inc, Teva Pharms Usa, Watson Labs, Allergan, Novartis, Akorn, Quagen, Wockhardt Bio Ag, Cintex Svcs, Encube, Glenmark Pharms, Novel Labs Inc, Padagis Israel, Cmp Pharma Inc, Lyne, Lupin Atlantis, Sanofi Aventis Us, Perrigo Pharma Intl, Sun Pharm Inds Inc, Rising, and Bausch And Lomb Inc, and is included in one hundred and thirty-three NDAs. There are seven patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Triamcinolone acetonide has one hundred and fifty patent family members in twenty-nine countries.

There are twenty-six drug master file entries for triamcinolone acetonide. Sixty-five suppliers are listed for this compound.

Drug Prices for triamcinolone acetonide

See drug prices for triamcinolone acetonide

Drug Sales Revenue Trends for triamcinolone acetonide

See drug sales revenues for triamcinolone acetonide

Recent Clinical Trials for triamcinolone acetonide

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Massachusetts Eye and Ear InfirmaryPhase 4
Nova Scotia Health AuthorityPhase 2/Phase 3
University of California, San FranciscoPhase 4

See all triamcinolone acetonide clinical trials

Pharmacology for triamcinolone acetonide
Medical Subject Heading (MeSH) Categories for triamcinolone acetonide

US Patents and Regulatory Information for triamcinolone acetonide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal TRIAMCINOLONE ACETONIDE triamcinolone acetonide INJECTABLE;INJECTION 207550-001 Dec 11, 2017 BX RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Lupin TRIAMCINOLONE ACETONIDE triamcinolone acetonide CREAM;TOPICAL 208763-003 Feb 1, 2017 AT RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Alkem Labs Ltd TRIAMCINOLONE ACETONIDE triamcinolone acetonide CREAM;TOPICAL 207651-002 Dec 26, 2017 AT RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Delcor Asset Corp KENALOG triamcinolone acetonide LOTION;TOPICAL 011602-001 Approved Prior to Jan 1, 1982 DISCN Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for triamcinolone acetonide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Delcor Asset Corp KENALOG-H triamcinolone acetonide CREAM;TOPICAL 086240-001 Approved Prior to Jan 1, 1982 See Plans and Pricing See Plans and Pricing
Abbvie AZMACORT triamcinolone acetonide AEROSOL, METERED;INHALATION 018117-001 Apr 23, 1982 See Plans and Pricing See Plans and Pricing
Chattem Sanofi NASACORT triamcinolone acetonide AEROSOL, METERED;NASAL 019798-001 Jul 11, 1991 See Plans and Pricing See Plans and Pricing
Chattem Sanofi NASACORT ALLERGY 24 HOUR triamcinolone acetonide SPRAY, METERED;NASAL 020468-002 Oct 11, 2013 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for triamcinolone acetonide

Country Patent Number Title Estimated Expiration
Japan 2016154873 極微針を使用した、眼組織への薬物送達のための方法および装置 (METHODS AND DEVICES FOR DRUG DELIVERY TO OCULAR TISSUE USING MICRONEEDLE) See Plans and Pricing
Japan 2016520383 眼球注射の装置および方法 See Plans and Pricing
Portugal 2262506 See Plans and Pricing
South Africa 201208069 METHODS AND DEVICES FOR DRUG DELIVERY TO OCULAR TISSUE USING MICRONEEDLE See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Colorcon
McKesson
Baxter
Express Scripts
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.